Advertisement | | Oncogenesis is an online-only, open access journal exploring the molecular basis of cancer and related phenomena. The journal seeks to promote diverse and integrated areas of molecular biology, cell biology, oncology, and genetics. The journal has an Impact Factor of 3.952.
Explore the benefits of submitting your next research article. | | | | | |
TABLE OF CONTENTS
| | | | Volume 35, Issue 18 (May 2016) | | In this issue Review Original Articles Short Communications
Also new AOP | | | | | Advertisement | | Open for Submissions
npj Precision Oncology is a new open access, online-only, peer-reviewed journal committed to publishing cutting-edge scientific research in all aspects of precision oncology from basic science to translational applications, to clinical medicine. The journal is part of the Nature Partner Journals series and published in partnership with The Hormel Institute, University of Minnesota.
Explore the benefits of submitting your manuscript >> | | | | | | Review | Top | | hPso4/hPrp19: a critical component of DNA repair and DNA damage checkpoint complexesK Mahajan Oncogene 2016 35: 2279-2286; advance online publication, September 14, 2015; 10.1038/onc.2015.321 Abstract | Full Text | | Original Articles | Top | | Imipramine blue halts head and neck cancer invasion through promoting F-box and leucine-rich repeat protein 14-mediated Twist1 degradationW-H Yang, Y-H Su, W-H Hsu, C-C Wang, J L Arbiser and M-H Yang Oncogene 2016 35: 2287-2298; advance online publication, August 10, 2015; 10.1038/onc.2015.291 Abstract | Full Text | | | | NF-κB1 p105 suppresses lung tumorigenesis through the Tpl2 kinase but independently of its NF-κB functionF Sun, Z Qu, Y Xiao, J Zhou, T F Burns, L P Stabile, J M Siegfried and G Xiao Oncogene 2016 35: 2299-2310; advance online publication, August 24, 2015; 10.1038/onc.2015.299 Abstract | Full Text | | | | Functional features of EVI1 and EVI1Δ324 isoforms of MECOM gene in genome-wide transcription regulation and oncogenicityA Sayadi, J Jeyakani, S H Seet, C-L Wei, G Bourque, F A Bard, N A Jenkins, N G Copeland and E A Bard-Chapeau Oncogene 2016 35: 2311-2321; advance online publication, August 3, 2015; 10.1038/onc.2015.286 Abstract | Full Text | | | | PIAS1 is a determinant of poor survival and acts as a positive feedback regulator of AR signaling through enhanced AR stabilization in prostate cancer OPENM Puhr, J Hoefer, A Eigentler, D Dietrich, G van Leenders, B Uhl, M Hoogland, F Handle, B Schlick, H Neuwirt, V Sailer, G Kristiansen, H Klocker and Z Culig Oncogene 2016 35: 2322-2332; advance online publication, August 10, 2015; 10.1038/onc.2015.292 Abstract | Full Text | | | | PTEN activation through K163 acetylation by inhibiting HDAC6 contributes to tumour inhibitionZ Meng, L-F Jia and Y-H Gan Oncogene 2016 35: 2333-2344; advance online publication, August 17, 2015; 10.1038/onc.2015.293 Abstract | Full Text | | | | Comprehensive proteomic profiling identifies the androgen receptor axis and other signaling pathways as targets of microRNAs suppressed in metastatic prostate cancerC Coarfa, W Fiskus, V K Eedunuri, K Rajapakshe, C Foley, S A Chew, S S Shah, C Geng, J Shou, J S Mohamed, B W O'Malley and N Mitsiades Oncogene 2016 35: 2345-2356; advance online publication, September 14, 2015; 10.1038/onc.2015.295 Abstract | Full Text | | | | Oncoprotein ZNF322A transcriptionally deregulates alpha-adducin, cyclin D1 and p53 to promote tumor growth and metastasis in lung cancer OPENJ Jen, L-L Lin, H-T Chen, S-Y Liao, F-Y Lo, Y-A Tang, W-C Su, R Salgia, C-L Hsu, H-C Huang, H-F Juan and Y-C Wang Oncogene 2016 35: 2357-2369; advance online publication, August 17, 2015; 10.1038/onc.2015.296 Abstract | Full Text | | | | Myeloid-specific TGF-β signaling in bone promotes basic-FGF and breast cancer bone metastasisX Meng, A Vander Ark, P Lee, G Hostetter, N A Bhowmick, L M Matrisian, B O Williams, C K Miranti and X Li Oncogene 2016 35: 2370-2378; advance online publication, August 17, 2015; 10.1038/onc.2015.297 Abstract | Full Text | | | | Spatiotemporal control of estrogen-responsive transcription in ERα-positive breast cancer cells OPENP-Y Hsu, H-K Hsu, T-H Hsiao, Z Ye, E Wang, A L Profit, I Jatoi, Y Chen, N B Kirma, V X Jin, Z D Sharp and T H-M Huang Oncogene 2016 35: 2379-2389; advance online publication, August 24, 2015; 10.1038/onc.2015.298 Abstract | Full Text | | | | Sustained adrenergic signaling leads to increased metastasis in ovarian cancer via increased PGE2 synthesisA S Nagaraja, P L Dorniak, N C Sadaoui, Y Kang, T Lin, G Armaiz-Pena, S Y Wu, R Rupaimoole, J K Allen, K M Gharpure, S Pradeep, B Zand, R A Previs, J M Hansen, C Ivan, C Rodriguez-Aguayo, P Yang, G Lopez-Berestein, S K Lutgendorf, S W Cole and A K Sood Oncogene 2016 35: 2390-2397; advance online publication, August 10, 2015; 10.1038/onc.2015.302 Abstract | Full Text | | Short Communications | Top | | The putative oncogene CEP72 inhibits the mitotic function of BRCA1 and induces chromosomal instabilityS Lüddecke, N Ertych, A Stenzinger, W Weichert, T Beissbarth, J Dyczkowski, J Gaedcke, O Valerius, G H Braus, M Kschischo and H Bastians Oncogene 2016 35: 2398-2406; advance online publication, August 24, 2015; 10.1038/onc.2015.290 Abstract | Full Text | | | | GNASR201H and KrasG12D cooperate to promote murine pancreatic tumorigenesis recapitulating human intraductal papillary mucinous neoplasmK Taki, M Ohmuraya, E Tanji, H Komatsu, D Hashimoto, K Semba, K Araki, Y Kawaguchi, H Baba and T Furukawa Oncogene 2016 35: 2407-2412; advance online publication, August 10, 2015; 10.1038/onc.2015.294 Abstract | Full Text | | | | | Advertisement | | | | | | | | | | | | Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.
Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com | | | | | | | | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. | | | | |
No comments:
Post a Comment
Keep a civil tongue.